Texas-Based CPRIT Allocates $21M to Texas-based Cancer Investigators & Ventures

Texas’ cancer-fighting agency, Cancer Prevention and Research Institute of Texas (CPRIT), is funding three Dallas-Fort Worth area startups with $3 million each to help turn their medical research into commercially viable products. The companies include Barricade Therapeutics Corp. (Fort Worth), Dialectic Therapeutics Inc. (Dallas), and Texas Magnetic Imaging Technology Inc. (Dallas). Texas also continues its raids for top oncologists on other major academic medical centers.

A $3 Billion Cancer Investment Fund

These grants are just the latest in $21 million worth of drug discovery and development financings made available by CPRIT. Created by Texas state legislature, voters approved an additional $3 billion investment for cancer research and prevention last fall 2019, adding to an earlier $3 billion commitment. The agency thus far has distributed $2.49 billion in grants to Texas-based research institutions, reports the Dallas Morning News. TrialSite News has discussed CPRIT in past articles.

Other Allocations

CPRIT recently awarded $1.137 million to a renowned muscle disease investigator, Eric Olson, at University of Texas Southwestern Medical Center to s...

Quality journalism costs money to produce. We will be reinvesting the proceeds of these subscriptions into an increasing volume of high quality, independent, unbiased reporting and expert analysis. Our subscription tiers use the ‘honor system’ – please do not abuse it. All tiers of service provide the same level of access to content. We are grateful for all of you, and we hope you reciprocate.

Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).